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ABSTRACT
Background:  Food allergy is often a life-long condition that requires constant vigilance in 
order  to  prevent  accidental  exposure  and  avoid  potentially  life-threatening  symptoms. 
Parents’ confidence in managing their child’s food allergy may relate to the poor quality of life  
anxiety and worry reported by parents of food allergic children.
Objective: The aim of the current study was to develop and validate the first scale to measure 
parental confidence (self-efficacy) in managing food allergy in their child.
Methods: The Food Allergy Self-Efficacy Scale for Parents (FASE-P) was developed through 
interviews with 53 parents, consultation of the literature and experts in the area.  The FASE-P 
was then completed by 434 parents of food allergic children from a general population sample 
in  addition  to  the  General  Self-Efficacy  Scale  (GSES),  the  Food  Allergy  Quality  of  Life 
Parental Burden Scale (FAQL-PB), the General Health Questionnaire (GHQ12) and the Food 
Allergy Impact Measure (FAIM).  A total of 250 parents completed the re-test of the FASE-P.
Results: Factor and reliability analysis resulted in a 21 item scale with 5 sub-scales.  The 
overall scale and sub-scales has good to excellent internal consistency (α’s of 0.63-0.89) and 
the scale is stable over time.  There were low to moderate significant correlations with the 
GSES, FAIM and GHQ12 and strong correlations with  the FAQL-PB, with better  parental  
confidence relating to better general self-efficacy, better quality of life and better mental health  
in the parent.  Poorer self-efficacy was related to egg and milk allergy; self-efficacy was not  
related to severity of allergy.
Conclusions and clinical relevance: The FASE-P is a reliable and valid scale for use with 
parents from a general population.  Its application within clinical settings could aid provision of 
advice  and  improve  targeted  interventions  by  identifying  areas  where  parents  have  less 
confidence in managing their child’s food allergy.
Key words: Food allergy, confidence, self-efficacy, parents, quality of life
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INTRODUCTION
Food allergy affects  approximately  5-10% of  children worldwide  [1-3].   In  the U.K. hospital 
admissions for food allergies increased by 6.4% in the 12 months leading to February 2014 
and of admissions for allergy nearly one in five were for anaphylactic reactions.  This is an  
increase of 9.4% from the same period the previous year [4].  There is no cure for food allergy 
and the optimum treatment is to avoid the allergen and anything that might have come into 
contact with the allergen; with the administration of antihistamine or adrenaline if accidental 
ingestion and a reaction occurs [1].  The vigilance required to manage food allergy and avoid 
allergens has been reported to place a significant burden on the family which can impact on  
health related quality of life[5], daily family activities and social events [6] and emotional well-
being [7].  Mothers in particular have reported high levels of stress and anxiety[5,8,9].   
Confidence in managing food allergy in their child may relate to the levels of burden felt by 
parents. Mandell et al.[9] interviewed parents of 17 children with peanut allergy who also had a 
history of anaphylaxis.   They found that a lack of information at diagnosis increased both 
anxiety and uncertainty in managing the risk of accidental ingestion of the allergen.  Parents 
have also reported high levels of worry about their child having an anaphylactic reaction and 
uncertainty around what to do if their child does go into anaphylactic shock [9,10].
Confidence and ‘the belief in one’s capabilities to organize and execute the courses of action 
required to manage prospective situations’ has been defined as self-efficacy (p. 2) [11] and is 
linked to how people think, feel and behave.  Improving self-efficacy can lead to individuals 
feeling  more  able  to  master  challenging  problems,  developing  a  stronger  sense  of 
commitment to dealing with these tasks and a reduction in feeling that situations are beyond 
their capabilities.  Improving self-efficacy has been shown to be effective in improving quality 
of  life,  self-management  and  coping  with  asthma  [12-14] and  other  long  term  conditions[15] 
through interventions  which  include  education,  training,  modelling  self-management  using 
case examples and role play scenarios with feedback, encouragement and support.
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Existing quality of life scales are good at identifying the extent of the impact of food allergy on 
various aspects of life but do provide information on areas in which confidence in being able 
to manage is lacking.  For example a quality of life scale might tell us that checking food 
labels takes up a lot of someone’s time but do not tell us if that person feels confident that 
they can identify allergens from food labels.  It would therefore be extremely useful to have a 
means of measuring self-efficacy for food allergy management to identify areas of low self-
efficacy. This may help health care practitioners to direct their advice to parents and also help  
the development and evaluation of interventions.  At present there is no means of measuring 
self-efficacy for food allergy management.   A widely  used General  Self-Efficacy Scale  [16] 
exists however this measures a general sense of perceived self-efficacy and aims to predict 
coping with daily hassles and other types of stress; it does not capture the specific issues that  
relate to food allergy.  The aim of this study was to develop and validate the first food allergy 
specific  self-efficacy scale  to  measure parental  confidence  in  managing their  child’s  food 
allergy.
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METHODS
Ethical  approval  for  the  scale  development  phase  of  this  study  was  provided  by  the 
Psychology  Research  Ethics  Committee  at  the  University  of  Derby  (012/10/RK)  and  the 
Nottingham Trent NHS Research Ethics Committee (10/H0405/94).  Ethical approval for the 
scale reliability and validity phase of this study was provided by the Psychology Research 
Ethics  Committee  at  the  University  of  Derby  (102-13-CB).   All  participants  gave  written 
informed consent to take part.
Item Generation 
Participants and procedure
Participants were recruited for interview via allergic clinics in the Midlands for a larger study 
looking at knowledge and understanding of food allergy in their child, how they managed their 
child’s food allergy and the impact it had on them.  Participants had to be parents of children 
with a current clinical diagnosis of food allergy (diagnosed by a clinician at an allergy clinic via  
clinical history and either skin prick tests or blood tests).  Parents were sent letters home by 
the clinic and they contacted the study team if  they wanted to participate.  Parents were 
mostly mothers (46 (86.8%); 7 (13.2%) fathers), with a mean age of 42.7 (range 32-59 years). 
Children had a mean age of 9.9 years and were allergic to peanut (60%), tree nut (54.5%), 
egg (12.7%) milk (12.7%), fruits and vegetables (10.9%).  Symptoms included urticaria, rash 
or hives (62.1%), swelling of face, lips, mouth and/or tongue (57.6%), vomiting (54.6%) and 
respiratory (37.9%).  The majority of the children had a prescribed adrenaline auto-injector 
(63.6%) and/or  antihistamines  (12.7%);  30.9% of  the  children  had  suffered  one  or  more 
anaphylactic reactions as a result of their food allergy.
All  parents were interviewed using a semi-structured interview schedule.   Following scale 
development guidelines [17-19] the interview schedule was informed by discussion with experts 
in the area; this included two psychologists with expertise in food allergy, a psychologist with 
expertise in self-efficacy in parents and two paediatric allergy consultants. Relevant literature 
on parental management of food allergy in their child was also reviewed.  Questions were 
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then developed to guide the interview.  The schedule was not intended to be prescriptive or 
inclusive but acted as a guide in the interview in order to ensure the aims of the study were 
met.  Parents were asked about how they managed food allergy in their child, what they found 
difficult or easy and what they felt they needed in order to be confident in managing food 
allergy.  They were also asked what they knew about food allergy, what they did to prevent an 
allergic reaction, what they did/would do if their child had an allergic reaction and how food 
allergy had made an impact on their  lives.   They were also asked about where they got 
information about food allergy from.
The interviews were audio taped and transcribed verbatim, then analysed by content analysis 
using a directed approach where you start with a theory and relevant research findings for 
guidance,  in  order  to  identify  specific  issues  that  parents  discussed  concerning  the 
management of food allergy for their child [20].  A literature review and advice from health care 
practitioners (detailed above) working in the area of food allergy also helped form items for 
inclusion in a prototype scale and items were revised to ensure there were no duplicates, 
unclear items or items that would not relate to the majority of parents of a child with food 
allergy.  Based on guidelines stated by Bandura[21] items were then worded as statements and 
parents were asked to rate how confident they were that they could do each item on a scale 
of 0 to 100 with 0 being cannot do at all, 50 being moderately can do and 100 being highly  
certain  can  do.   The  prototype  Food  Allergy  Self-Efficacy  Scale  for  Parents  (FASE-P) 
consisted of 22 items such as being able to prepare to go to a restaurant, go on holiday, 
check food labels and get information about food allergy from a health care professional.
Scale reliability and validity
Participants and procedure
In order to assess reliability and validity of the scale on a large sample, participants were 
recruited from the general population via advertisement of an online survey through social 
media  channels  such  as  Facebook  and  Twitter  and  through  the  Anaphylaxis  Campaign 
Charity’s website.  Emails advertising the study were also sent to all eligible members of the 
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Campaign  although parents  did  not  need  to  be  members  of  the  Campaign  to  take  part. 
Inclusion criteria for the study were that the participant was a parent who had at least one 
child under the age of 18 years living in the family home who had a food allergy diagnosed by  
a clinician at an allergy clinic.  Participants completed the questionnaires anonymously but 
were  asked  to  provide  their  email  address  if  they were  happy to  complete  some of  the 
questionnaires three weeks later.   A total of 250 participants completed the re-test of the 
FASE-P.
Cross-sectional validation measures
In addition to completing the FASE-P parents also completed a number of validated scales in 
order to assess construct validity.
General Self-Efficacy Scale [16] is a 10 item scale measuring general perceived self-efficacy. 
Responses are made on a 4 point scale from 1 (not at all true) to 4 (exactly true).  An example 
item is:  I  can always  manage to solve difficult  problems if  I  try  hard enough.   Items are 
summed with  higher  scores indicating greater  self-efficacy.   In  samples from 23 nations, 
Cronbach’s alphas ranged from .76 to .90 with the majority in the high .80s [22].
Food Allergy Quality of Life – Parental Burden (FAQL-PB) scale [23]   has 17 items and uses a 
7-point Likert scale ranging from 1 (not troubled) to 7 (extremely troubled).  Questions include 
issues concerning going on vacation,  social  activities  and worries  and anxieties over  the 
previous week.  A higher score indicates greater parental burden.  Internal validity has been 
reported as excellent in a U.S. sample (Cronbachs α = 0.95)  [23] and in a U.K. sample (α > 
0.85) [24].
Food  Allergy  Independent  Measure  (FAIM)  has  4  items  which  measure  the  severity  of 
perceived risk  of  an accidental  reaction to food and the risk  of  not  being able to treat  a 
reaction appropriately.  It has been used as a means of measuring the impact of food allergy  
in  the validation of  other  related questionnaires such as the Food Allergy  Quality  of  Life 
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Scales [25-27].  Items are answered on a 7-point Likert scale with a greater score indicating a  
higher level of perceived seriousness.
General Health Questionnaire – 12 (GHQ-12) [28] is a 12 item scale of current mental health 
which asks individuals to state how they have felt  over the last few weeks.   It  measures 
inability  to  carry  out  normal  functions  and  also  the  appearance  of  new  and  distressing 
symptoms.  It uses a 4 point Likert scale from not at all (scored 0) to much more than usual  
(scored 3).  Scores are summed and have a range from 0 to 36.  Scores over 11-12 indicate a 
risk of being diagnosed with a mental illness.  The scale has excellent internal consistency 
(Cronbach’s α = 0.77-0.93) and good validity [28].
Demographic and food allergy questionnaire
In order to assess  discriminative validity a questionnaire to gather demographic information 
from the parent and food allergy information about their child was developed based on that 
used in previous published studies[29].  Information collected included the type of food allergy, 
symptoms, how the allergy was diagnosed, medication, history of anaphylaxis and presence 
of other atopic conditions such as asthma, hay-fever and eczema.
Statistical analysis
Data analyses were conducted using SPSS version 21, and all tests were 2-tailed with a 
significance level set at p<0.05, missing data was treated pairwise.  Principle components 
analysis with a varimax rotation was conducted to assess internal structural validity. 
Reliability analysis was conducted in order to calculate the internal consistency of the scale 
using Cronbach’s α coefficient and Guttman’s split-half coefficient.  Pearson’s bivariate 
correlations were conducted between scale scores to assess construct and convergent 
validity.   Intra-Class Correlations were conducted to assess temporal stability of the scale. 
Following criteria set out by Pesudov et al [18] and results reported by other similar scales such 
as the food allergy specific QoL scales [25-27], a priori hypotheses were set regarding reliability 
and validity.  We expected Cronbach’s alpha of >0.7 and <0.9 and moderate construct validity 
8
correlations of >0.3 with sub-scales measuring similar aspects to the scale.  Specifically we 
expected that greater food allergy self-efficacy would positively relate to greater general self-
efficacy and better food allergy related quality of life.  We also expected that greater food 
allergy self-efficacy would negatively relate to poorer mental health and greater severity of 
perceived risk of food allergy.  Between-subjects t-tests and Pearson’s correlations were 
performed to assess the discriminative validity of the FASE-P by comparing demographic and 
food allergy characteristics.  Analyses of Covariance (ANCOVAs) were run to assess 
discriminative validity of the FASE-P controlling for possible confounders.
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RESULTS
Demographic information for participants in the reliability and validity phase can be found in 
Table 1 and food allergy information can be found in Table 2.
Structural validity
Principle components analysis with a varimax rotation was conducted on the 22 items of the 
FASE-P.  The Kaiser-Meyer-Olkin Measure of Sampling Adequacy was .83, exceeding the 
recommended value of .6  [30] and Bartlett’s Test of Sphericity (4577.90,  df  = 231,  p<0.001) 
reached statistical  significance, supporting the factorability  of  the correlation matrix.  Five 
factors with Eigenvalues over 1, explaining a total of 59.8% of the variance in the scores, 
were identified.  All  items had factor loadings greater than 0.4 and factors were labelled:  
precaution and prevention, allergic treatment, food allergen identification, seeking information, 
managing social activities (Table 3).  
The item ‘planning to participate in social activities with others involving food’ loaded onto the 
sub-scale  entitled  managing  social  activities  and  the  sub-scale  entitled  precaution  and 
prevention.  The highest loading was for the precaution and prevention sub-scale and as the  
item concerned planning it was placed there.  Two other items had factor loadings above 0.4  
on two subscales, but loadings were very similar and so items were placed on the factor that  
had the greatest face validity and made the most theoretical sense.
Reliability and consistency over time of the PFA-QL
The FASE-P scale had excellent internal consistency with a Cronbach’s α of 0.88 overall.  
Split half Cronbach’s α for part 1 was .76 and .86 for part 2; the Guttman split-half coefficient  
was 0.73.  Examination of the alpha levels if items were deleted revealed that removal of the  
item ‘treat my child if they had an allergic reaction outside of the home’ increased the alpha of 
the allergic reaction sub-scale from .29 to .80.  This item was therefore removed from the 
scale and the item ‘treat my child if they had an allergic reaction at home’ was re-worded to 
say  ‘treat  my child  if  they  had  an allergic  reaction’  to  ensure  this  item captured  allergic  
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reactions wherever they occurred.  The alpha coefficient values decreased with deletion of  
any of the other items in each of the sub-scales, indicating that all items were important to the 
scale and so were retained.  Alphas for all sub-scales can be seen in Table 4.  The final scale 
consists of 21 items.  Answers on the scale are totalled (there are no reverse items) and then 
divided by 21 to get a total mean score, resulting in a score range from 0 to 100.  Sub-scale 
items are similarly totalled and divided by the number of items in each sub-scale.  A higher 
score indicates greater self-efficacy for food allergy management.
Two hundred and fifty participants completed a re-test of the FASE-P after three weeks.  Of 
those parents who reported no change in their own physical or mental health (n=186) there 
was a strong intra-class correlation of .816.  For those who reported no allergic reactions in 
their child in the last three weeks (n=163) there was also a strong intra-class correlation of .
801.  There was however a slight but significant increase in the mean scores from time one to  
time two in  parents who reported no change in  their  own health  (mean=72.89 vs  74.30,  
t(185)=-2.86,  p=0.005)  and  in  parents  who  reported  no  allergic  reaction  in  their  child  
(mean=72.92 vs 74.71, t(162)=-3.33, p=0.001).
Construct Validity
The total FASE-P score significantly correlated with the total generalised self-efficacy score 
(r=.24, p<0.001) with greater food allergy specific self-efficacy relating to greater general self-
efficacy.  This was in the hypothesised direction but was slightly lower than the expected 
correlation of around 0.3, which is probably due to the FASE-P measuring specific aspects of 
food allergy related self-efficacy rather than just general self-efficacy.  Each item of the FASE-
P also significantly correlated with the GSES with r values ranging from .10 to .22 (all p values 
<0.05) apart from two items relating to the ability to get information about food allergy from the 
GP, nurse or family doctor (r=.06) and from food retailers (r=.08).  These items had good 
factor loadings, good inter-item correlations, did not increase the alpha of the scale if deleted 
and were rated as important items to keep by the study team and were therefore retained in  
the scale.
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In line with expectations, the total FASE-P score had a strong significant correlation with the 
FAQL-PB (r=-.56, p<0.001), demonstrating that greater confidence in managing their child’s 
food  allergy  was  related  to  less  parental  burden.   The  FASE-P also  correlated  with  the  
GHQ12 (r=-.31, p<0.001) showing that greater confidence was related to better mental health 
(lower scores on the GHQ12).
There were  negative  correlations between the FASE-P and the FAIM total  score (r=-.22, 
p<0.001) demonstrating that parents who rated their child’s risk of a negative outcome such 
as an allergic reaction or death as less severe had greater confidence in managing food 
allergy in their child.
Discriminative validity of the PFA-QL
FASE-P scores were significantly correlated with the age of the parent (r=.22, p<0.001) and 
the child (r=0.26, p<0.001) indicating that older parents and parents of older children reported 
greater confidence in managing their child’s food allergy.   FASE-P scores were negatively 
correlated with the number of food allergies the child had (r=-.15, p<0.05) showing that the  
more allergies the child had the less confidence the parent had.  FASE-P scores were not  
correlated to the number of times their child had reacted or to the number of children they had  
living at home with food allergy.   There was no difference in parental  self-efficacy scores 
between mothers and fathers,  however parents of boys with  food allergy had higher self-
efficacy scores (mean=76.91, SD=11.07) than parent of girls with food allergy (mean=74.53, 
SD=11.83), (t(413)=2.04,p<0.05).
There was no significant difference in self-efficacy scores between parents who had children 
who had suffered from anaphylaxis and those who had not, or those whose child had been 
admitted to hospital because of food allergy and those who had not.  Numbers of children 
carrying an adrenaline auto-injector was high (n=395) compared to those not (n=19); self-
efficacy  scores  for  parents  were  marginally  greater  for  those  with  an  AAI  (mean=76.37, 
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SD=11.12) compared to those without (mean=71.93, SD=12.95) but this was not significant 
(t(412)=1.67, p=0.09).
There were no differences in self-efficacy scores for parents of children who had asthma, 
eczema and hay-fever or those who had allergies to peanuts or other nuts compared to those 
who did not.  Parents of children who had allergy to cow’s milk had lower self-efficacy scores 
(n=114, mean=73.38, SD=12.16) than those who did not (n=304, mean=77.08, SD=10.91), 
(t(416)=-2.99, p=0.003).  Similarly parents of children who had allergy to egg had lower self-
efficacy  scores  (n=155,  mean=73.09,  SD=12.40)  than  those  who  did  not  (n=263, 
mean=77.83, SD=10.35), (t(416)=-.4.20, p<0.001).  As there was a significant relationship 
between parental self-efficacy and age of child, age might be a reason for the differences 
seen  in  children  with  milk  and  egg  allergy.   To  assess  this  Analyses  of  Covariance 
(ANCOVAs) were run.  After controlling for age of child there was still a significant difference 
between parents of children with egg allergy or not (F=18.46, p<0.001) and also a significant 
difference between parents of children with milk allergy or not (F=15.54, p<0.001).
13
DISCUSSION
The FASE-P is the first self-efficacy scale to measure confidence in parental management of 
their child’s food allergy.  It has excellent internal reliability overall, satisfactory to excellent 
internal  reliability  for  the  sub-scales  and  excellent  reliability  over  time  in  parents  from a 
general population.  Scores did increase slightly from time one to time two and it may be that  
completing the scale itself acted as an intervention, prompting parents to think more about 
how they  manage their  child’s  food allergy  over  the  following  two  weeks  and  feel  more  
confident  in  doing  so.   The  scale  also  had  good  construct  validity  as  demonstrated  by 
convergent validity correlations with the GSES, FAQL-PB, GHQ-12 and FAIM.  Correlations 
were  significant  but  slightly  lower  than  expected  with  the  GSES,  probably  reflecting  the 
generic  nature  of  the  GSES,  which  does  not  identify  the  specific  issues  important  for 
management of food allergy.  Previous studies have also found only moderate correlations 
between  general  and  parental  self-efficacy,  showing  that  generalised  self-efficacy  is  not 
sensitive enough to measure behaviour specific self-efficacy [31].
Correlations between the FASE-P and the FAQL-PB were strong demonstrating that greater 
food allergy specific self-efficacy seems to be an important determinant for better quality of  
life, although causation cannot be ascertained from this study.  There was also a significant 
relationship between greater self-efficacy and better mental health as measured by the GHQ-
12,  although  correlations  were  not  as  strong,  probably  due  to  mental  health  issues  as 
measured by the GHQ-12 being non-specific rather than attributed to food allergy.  Although 
correlations with the FAIM were significant they were low, which may be because parents 
from this general population sample view the chance of a severe reaction or death in their  
child differently to their ability to manage their child’s condition on a daily basis.  Parents have 
reported extreme worry and concern regarding the risk of anaphylaxis and their ability to deal 
with that  [9,  10,  32] but parents in this sample may have felt more confident in their ability to 
manage other aspects of their child’s food allergy.
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An important and novel finding from this study was that discriminative validity of the FASE-P 
showed that parents had less self-efficacy when their children had milk or egg allergy.  There 
was no difference in parents of children with peanut or nut allergy or not.  This interesting 
finding indicates that parents may struggle to manage a food allergy where allergens are a  
main ingredient in a wide range of foods (such as milk and egg) rather than foods were traces 
of the allergen may be contained in foods (such as peanut and nut).  This finding was still  
significant after controlling for the age of the child, demonstrating that age was not affecting 
the results.  Much emphasis in the recent past has been placed on the significant impact of 
peanut and nut allergy on families rather than to other foods  [e.g.  5,29].  The finding from this 
study highlights the importance of measuring parental confidence in managing food allergy in 
addition to impact on quality of life, as results may help ensure the right advice and support is  
offered to families who need it.
Another important finding from this study was the lack of difference in FASE-P scores on 
measures  of  the  severity  of  food  allergy  such  as  experience  of  anaphylaxis  and 
hospitalisation due to food allergy.  Lack of confidence in managing food allergy is therefore  
just as likely in parents of children who have not had a severe reaction, which is an important  
consideration  for  health  care  professionals  giving  advice  and  training  in  food  allergy 
management.  Experience of anaphylaxis has been reported to relate to outcomes such as 
quality of life in some [27]  but not all  [33] populations.  Knibb et al.  [33] suggest there may be a 
mediating effect such as age of child or time since anaphylactic reaction that needs to be 
investigated in future studies.  Indeed age of child did correlate with the FASE-P scores as did  
age of the parent showing that as parent and child got older, confidence in managing the food 
allergy  increased.  It  may  be  that  parent’s  life  experience  or  food  allergy  management 
experience contributes to this finding. The scale also did not discriminate between those with 
an  adrenaline  auto-injector  or  not,  although  this  might  have  been  because  almost  all 
participants in the sample had been prescribed one of these.
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A strength of this study is the large sample of parents that the scale has been validated on 
and in particular the large sample conducting the re-test.  As with all research of this nature, 
the sample was self-selected and motivated to take part and may therefore be different in 
some way to parents of food allergic children who did not take part.  Nevertheless, recruiting a 
large sample from a general population rather than an allergy clinic enabled us to gather data 
encompassing a wide range of food allergy characteristics, including parents with children 
who had been diagnosed for a number of years as well as those with more recent diagnoses.  
Although we only included parents whose child  had been diagnosed by a clinician at  an 
allergy clinic, we necessarily had to rely on self-report of parents for the reliability and validity 
phase of  the study.   Given the number of children who had been prescribed AAIs in the  
sample it is unlikely that a large number will have misreported the diagnosis.  In addition, the  
wide range of scores on the FASE-P indicates that the sample consisted of parents across 
the spectrum and so issues such as membership of a support group should not have unduly 
affected the results.  
Nevertheless,  further  validation on  a  sample recruited from a  clinical  database would  be 
useful  to  ensure  self-report  of  a  clinical  diagnosis  in  the  child  has  not  affected  results. 
Confirmatory factor analysis is also needed to confirm the sub-scales found in the exploratory 
factor  analysis  reported here.   It  is  also unknown whether  greater  self-efficacy relates to 
accurate knowledge and skills in food allergy management. There is evidence to suggest that 
better  self-efficacy does correlate  with  better parental  management  of  conditions such as 
diabetes  in  relation  to  outcomes  such  as  glycaemic  control  [34],  but  this  needs  to  be 
investigated specifically for food allergy.  Development of a short version of the scale may 
also be useful for use in clinical settings to identify broad areas where families are struggling 
to manage.
To conclude, the FASE-P is  a reliable and valid  tool  to use with a general  population of 
parents of children with food allergy.  The relationship of parental confidence in managing 
food allergy to the severity of food allergy and to the foods involved has been found to be  
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different  to  previous research focusing on quality  of  life.  It  is  therefore important  for self-
efficacy to be measured in order to direct appropriate health care advice.
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Table 1.  Characteristics of respondents (n %) for the reliability and validity phase of the scale 
development
Where  % 
don’t  add up 
to  100  there 
are  missing 
values; 
where  % 
total  more 
than  100 
parents were 
able to select 
more  than 
one answer.
 Sample n=434
n/%
Parents age (mean, s.d.) 42.21 (6.41)
Sex of Parent completing survey
     Male 19 (4.4%)
     Female 411 (94.7%)
Marital status
Married/living with partner 393 (90.5)
Divorced 16 (3.7)
Single 17 (3.9)
Widowed 1 (0.2)
Employment status
Working full-time 123 (28.3)
Working part-time 204 (47.0)
Full-time education 3 (0.7)
Not working or in education 102 (23.5)
Country of residence
     UK 410 (94.5)
     Other EU 12 (2.8)
     Non-EU 8 (1.8)
Number of children within family (mean, s.d.) 2.03 (1.12)
Number of children in family with a food allergy
     One 382 (88)
     Two 44 (10.1)
     Three 6 (1.4)
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Table 2. Food allergy characteristics (n %) for the reliability and validity phase of the scale 
development.
Sample n=434
n/%
Child age in years (mean, s.d.) 9.47 (4.7)
Child age range (years) 1-18
Sex of child with food allergy                    
     Male 282 (65)
     Female 148 (34.1)
Foods reported
     Peanut 335 (77.2)
     Tree nut 287 (66.1)
     Both peanut and tree nut 265 (54.1)
     Cows Milk 119 (27.4)
     Egg 162 (37.3)
     Soya 30 (6.9)
     Fruit 54 (12.4)
     Fish 32 (7.4)
     Sesame 43 (9.9)
     Wheat 16 (3.68)
     Shellfish 34 (7.8)
Symptoms reported
     Vomiting 228 (52.5)
     Abdominal Pain 155 (35.7)
     Rash, hives, urticaria 324 (74.7)
     Facial swelling 280 (64.5)
     Breathing difficulties 214 (49.3)
     Throat tightening 177 (40.8)
Table 1 continued
Other allergies
     Latex 14 (3.2)
     Tree Pollen 111 (25.6)
     Grass Pollen 121 (27.9)
Asthma 310 (71.4)
Eczema 366 (84.3)
Hayfever 240 (55.3)
History of Anaphylaxis 226 (52.1)
Carries Adrenaline Auto Injector 411 (94.7)
How allergy diagnosed
Skin prick test 327 (75.3)
     Blood test 265 (60.8)
     Food challenge 66 (15.2)
Hospitalisation due to an allergic reaction 
to food
282 (65)
Where % don’t add up to 100 there are missing values; where % total more than 100 parents 
were able to select more than one answer.
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Table 3.  Factor analysis for the FASE-P scale and sub-scales
Factor Loadings
MANAGING SOCIAL ACTIVITIES 1 2 3 4 5
Be on holiday/vacation abroad .849
Plan for a holiday/vacation abroad .838
Be on holiday/vacation in this country .757
Plan for a holiday/vacation in this country .744
Eat at a restaurant .670
Prepare to go to a restaurant .621
PRECAUTION & PREVENTION
Have a plan to make sure my child is safe at school or nursery .703
Have a plan to make sure my child is safe with a relatives, 
friends or a babysitter
.678
Plan to participate in social activities with others involving food 
(e.g. parties)
.426 .630
Control my child’s environment to prevent an accidental 
exposure
.490
Teach others about my child’s food allergy .463
Prepare to go out of the home with my child .424
ALLERGIC TREATMENT
Recognise an allergic reaction in my child .755
Treat my child if they had an allergic reaction at home .772
Treat my child if they had an allergic reaction outside of the 
home
.424
FOOD ALLERGEN IDENTIFICATION
Identify possible food cross-contamination .759
Check food labels .712
Prepare homemade meals .501 .446
SEEKING INFORMATION ABOUT FOOD ALLERGY
Get information about my child’s food allergy from:
G.P. nurse or family doctor .768
Food retailers (e.g. supermarkets, food outlets) .724
Websites .623
Paediatrician or allergy specialist at the hospital .448 .408
Eigenvalues 3.97 2.80 2.26 2.17 1.96
% variance 18.03 12.74 10.26 9.88 8.89
Table 4. Cronbach’s alphas for the FASE-P scale and sub-scales.
FASE-P Cronbach’s alphas
Total Scale .88
Sub-Scales
Managing Social Activities .89
Precaution & Prevention .74
Allergic Treatment .80*
Food Allergen Identification .63
Seeking Information About Food Allergy .65
*  With the removal of the item ‘treat my child if they had an allergic reaction outside of the 
home’.
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